Tata India Pharma & Healthcare Fund Regular Growth
- Sector - Healthcare
- Equity
- Very High Risk
Explore On
Rating:
Key Metrics
Aum
₹1,386.99 Cr
Expense Ratio
1.84%
Exit Load
0.25%
Min. Investment
₹5,000.00
Min. SIP
₹100.00
Launch Date
28 Dec 2015
CAGR Returns
| Period | Absolute(%) | Annualised(%) |
|---|---|---|
| 1 Month | -1.09% | -- |
| 3 Months | +4.56% | -- |
| 6 Months | +2.66% | -- |
| 1 Year | +3.99% | +3.99% |
| 2 Years | -- | +9.42% |
| 3 Years | +81.62% | +22.01% |
| 5 Years | +82.51% | +12.79% |
| Since Launch | +212.25% | +11.51% |
Holdings as on 14 June 2026
| Name | Value (₹Cr) | Holding % |
|---|---|---|
| Sun Pharmaceutical Industries | 130.77 | 9.87 |
| Divi's Laboratories | 78.43 | 5.92 |
| HealthCare Global Enterprises Ltd | 72.25 | 5.45 |
| Abbott India | 71.10 | 5.37 |
| Max Healthcare Institute | 68.57 | 5.17 |
| Cipla | 67.16 | 5.07 |
| Rainbow Children's Medicare | 56.00 | 4.23 |
| Apollo Hospitals Enterprise | 53.83 | 4.06 |
| Mankind Pharma | 49.44 | 3.73 |
| Dr Reddy's Laboratories | 49.41 | 3.73 |
Morning Star Rating
Rating:
Risk
Return
Risk & Volitility
0.92
Sharpe Ratio
17.10%
Std. Deviation
10.07%
Tracking Error
11.23%
Alpha
0.70
Beta
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare Fund Regular Plan Growth | +9.33% | +26.21% | +13.75% |
| Mirae Asset Healthcare Fund Regular Growth | +10.91% | +24.65% | +13.83% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth | +9.94% | +23.4% | +12.25% |
| Tata India Pharma & Healthcare Fund Regular Growth | +3.99% | +22.01% | +12.79% |
| HDFC Pharma and Healthcare Fund Regular Growth | +17.27% | -- | -- |
Results are calculated on CAGR basis
About Fund
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 1386.99 crores & has delivered CAGR of 12.79 in the last 5 years. The fund has an exit load of 0.25% and an expense ratio of 1.84%. The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 100.
As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.
The fund has a present cash holding of %. The top holdings of the fund include Sun Pharmaceutical Industries, Divi's Laboratories, HealthCare Global Enterprises Ltd, Abbott India.
The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Chemical Manufacturing, Major Drugs.
Some of the similar funds are UTI Healthcare Fund Regular Plan Growth, Mirae Asset Healthcare Fund Regular Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, Tata India Pharma & Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth. Tata India Pharma & Healthcare Fund Regular Growth has a sharpe ratio of 0.92 & a standard deviation of 17.10%.
FAQs
According to the morning star rating Tata India Pharma & Healthcare Fund Regular Growth has a Medium risk & Exceptional return.
Tata India Pharma & Healthcare Fund Regular Growth is managed by Rajat Srivastava.
The expense ratio of Tata India Pharma & Healthcare Fund Regular Growth is 1.84%.
The 5 year annualized return on Tata India Pharma & Healthcare Fund Regular Growth is 12.79% & it has generated 3.99% in the last 1 year.
The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is 5000 Rs.
Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 1386.99 crores.
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.